nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CASR—parathyroid gland—thyroid cancer	0.166	0.623	CbGeAlD
Cinacalcet—CYP1A2—Sorafenib—thyroid cancer	0.0978	0.248	CbGbCtD
Cinacalcet—CYP3A4—Vandetanib—thyroid cancer	0.085	0.215	CbGbCtD
Cinacalcet—CYP2D6—Sorafenib—thyroid cancer	0.0806	0.204	CbGbCtD
Cinacalcet—CYP3A4—Sorafenib—thyroid cancer	0.0512	0.13	CbGbCtD
Cinacalcet—CASR—neck—thyroid cancer	0.0502	0.189	CbGeAlD
Cinacalcet—CYP2D6—Doxorubicin—thyroid cancer	0.0489	0.124	CbGbCtD
Cinacalcet—CYP3A4—Doxorubicin—thyroid cancer	0.0311	0.0788	CbGbCtD
Cinacalcet—CASR—thyroid gland—thyroid cancer	0.0239	0.0899	CbGeAlD
Cinacalcet—CASR—head—thyroid cancer	0.0212	0.0797	CbGeAlD
Cinacalcet—Carcinoma—Sorafenib—thyroid cancer	0.0162	0.0481	CcSEcCtD
Cinacalcet—Hypercalcaemia—Vandetanib—thyroid cancer	0.0105	0.031	CcSEcCtD
Cinacalcet—Ventricular arrhythmia—Vandetanib—thyroid cancer	0.00981	0.0291	CcSEcCtD
Cinacalcet—Metastatic neoplasm—Epirubicin—thyroid cancer	0.00944	0.028	CcSEcCtD
Cinacalcet—Metastatic neoplasm—Doxorubicin—thyroid cancer	0.00874	0.0259	CcSEcCtD
Cinacalcet—Hypocalcaemia—Vandetanib—thyroid cancer	0.00793	0.0235	CcSEcCtD
Cinacalcet—Neoplasm malignant—Sorafenib—thyroid cancer	0.00574	0.017	CcSEcCtD
Cinacalcet—Multi-organ failure—Epirubicin—thyroid cancer	0.00555	0.0165	CcSEcCtD
Cinacalcet—Bone disorder—Sorafenib—thyroid cancer	0.00542	0.0161	CcSEcCtD
Cinacalcet—Cardiac failure—Vandetanib—thyroid cancer	0.0054	0.016	CcSEcCtD
Cinacalcet—Hypocalcaemia—Sorafenib—thyroid cancer	0.00535	0.0159	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.00527	0.0156	CcSEcCtD
Cinacalcet—Multi-organ failure—Doxorubicin—thyroid cancer	0.00514	0.0152	CcSEcCtD
Cinacalcet—Dehydration—Vandetanib—thyroid cancer	0.0049	0.0145	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00423	0.0125	CcSEcCtD
Cinacalcet—Depression—Vandetanib—thyroid cancer	0.00405	0.012	CcSEcCtD
Cinacalcet—Cardiac failure—Sorafenib—thyroid cancer	0.00364	0.0108	CcSEcCtD
Cinacalcet—Pain in extremity—Sorafenib—thyroid cancer	0.00356	0.0105	CcSEcCtD
Cinacalcet—Dehydration—Sorafenib—thyroid cancer	0.00331	0.0098	CcSEcCtD
Cinacalcet—Arrhythmia—Vandetanib—thyroid cancer	0.00326	0.00965	CcSEcCtD
Cinacalcet—Malnutrition—Vandetanib—thyroid cancer	0.00317	0.00941	CcSEcCtD
Cinacalcet—Muscle spasms—Vandetanib—thyroid cancer	0.00305	0.00904	CcSEcCtD
Cinacalcet—CYP1A2—thyroid gland—thyroid cancer	0.00296	0.0112	CbGeAlD
Cinacalcet—Cough—Vandetanib—thyroid cancer	0.00277	0.00821	CcSEcCtD
Cinacalcet—Convulsion—Vandetanib—thyroid cancer	0.00275	0.00815	CcSEcCtD
Cinacalcet—Hypertension—Vandetanib—thyroid cancer	0.00274	0.00812	CcSEcCtD
Cinacalcet—Chest pain—Vandetanib—thyroid cancer	0.0027	0.00801	CcSEcCtD
Cinacalcet—Arthralgia—Vandetanib—thyroid cancer	0.0027	0.00801	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00268	0.00795	CcSEcCtD
Cinacalcet—Hypercalcaemia—Epirubicin—thyroid cancer	0.00261	0.00772	CcSEcCtD
Cinacalcet—Infection—Vandetanib—thyroid cancer	0.00257	0.00763	CcSEcCtD
Cinacalcet—Thrombosis—Epirubicin—thyroid cancer	0.00256	0.00758	CcSEcCtD
Cinacalcet—Nervous system disorder—Vandetanib—thyroid cancer	0.00254	0.00753	CcSEcCtD
Cinacalcet—Skin disorder—Vandetanib—thyroid cancer	0.00252	0.00746	CcSEcCtD
Cinacalcet—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00245	0.00725	CcSEcCtD
Cinacalcet—Hypercalcaemia—Doxorubicin—thyroid cancer	0.00241	0.00714	CcSEcCtD
Cinacalcet—Thrombosis—Doxorubicin—thyroid cancer	0.00237	0.00701	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00236	0.00699	CcSEcCtD
Cinacalcet—Floctafenine—PTGS2—thyroid cancer	0.00235	1	CrCbGaD
Cinacalcet—Paraesthesia—Vandetanib—thyroid cancer	0.00233	0.00689	CcSEcCtD
Cinacalcet—Dyspnoea—Vandetanib—thyroid cancer	0.00231	0.00684	CcSEcCtD
Cinacalcet—Dyspepsia—Vandetanib—thyroid cancer	0.00228	0.00676	CcSEcCtD
Cinacalcet—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00226	0.00671	CcSEcCtD
Cinacalcet—Decreased appetite—Vandetanib—thyroid cancer	0.00225	0.00667	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00224	0.00663	CcSEcCtD
Cinacalcet—Fatigue—Vandetanib—thyroid cancer	0.00223	0.00662	CcSEcCtD
Cinacalcet—Immune system disorder—Sorafenib—thyroid cancer	0.00222	0.00658	CcSEcCtD
Cinacalcet—Constipation—Vandetanib—thyroid cancer	0.00222	0.00656	CcSEcCtD
Cinacalcet—Arrhythmia—Sorafenib—thyroid cancer	0.0022	0.00651	CcSEcCtD
Cinacalcet—Malnutrition—Sorafenib—thyroid cancer	0.00214	0.00634	CcSEcCtD
Cinacalcet—Neoplasm malignant—Epirubicin—thyroid cancer	0.00212	0.00628	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00212	0.00628	CcSEcCtD
Cinacalcet—Muscle spasms—Sorafenib—thyroid cancer	0.00206	0.0061	CcSEcCtD
Cinacalcet—Abdominal pain—Vandetanib—thyroid cancer	0.00205	0.00607	CcSEcCtD
Cinacalcet—Body temperature increased—Vandetanib—thyroid cancer	0.00205	0.00607	CcSEcCtD
Cinacalcet—Bone disorder—Epirubicin—thyroid cancer	0.002	0.00594	CcSEcCtD
Cinacalcet—Anaemia—Sorafenib—thyroid cancer	0.00198	0.00586	CcSEcCtD
Cinacalcet—Hypocalcaemia—Epirubicin—thyroid cancer	0.00198	0.00586	CcSEcCtD
Cinacalcet—Neoplasm malignant—Doxorubicin—thyroid cancer	0.00196	0.00581	CcSEcCtD
Cinacalcet—Angioedema—Sorafenib—thyroid cancer	0.00196	0.0058	CcSEcCtD
Cinacalcet—CYP2D6—head—thyroid cancer	0.00187	0.00705	CbGeAlD
Cinacalcet—Cough—Sorafenib—thyroid cancer	0.00187	0.00554	CcSEcCtD
Cinacalcet—Asthenia—Vandetanib—thyroid cancer	0.00186	0.00551	CcSEcCtD
Cinacalcet—Bone disorder—Doxorubicin—thyroid cancer	0.00185	0.00549	CcSEcCtD
Cinacalcet—Hypertension—Sorafenib—thyroid cancer	0.00185	0.00548	CcSEcCtD
Cinacalcet—Pruritus—Vandetanib—thyroid cancer	0.00183	0.00543	CcSEcCtD
Cinacalcet—Hypocalcaemia—Doxorubicin—thyroid cancer	0.00183	0.00542	CcSEcCtD
Cinacalcet—Myalgia—Sorafenib—thyroid cancer	0.00182	0.0054	CcSEcCtD
Cinacalcet—Arthralgia—Sorafenib—thyroid cancer	0.00182	0.0054	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00181	0.00536	CcSEcCtD
Cinacalcet—Diarrhoea—Vandetanib—thyroid cancer	0.00177	0.00525	CcSEcCtD
Cinacalcet—Infection—Sorafenib—thyroid cancer	0.00174	0.00514	CcSEcCtD
Cinacalcet—Nervous system disorder—Sorafenib—thyroid cancer	0.00171	0.00508	CcSEcCtD
Cinacalcet—Dizziness—Vandetanib—thyroid cancer	0.00171	0.00508	CcSEcCtD
Cinacalcet—Skin disorder—Sorafenib—thyroid cancer	0.0017	0.00503	CcSEcCtD
Cinacalcet—Anorexia—Sorafenib—thyroid cancer	0.00167	0.00494	CcSEcCtD
Cinacalcet—Vomiting—Vandetanib—thyroid cancer	0.00165	0.00488	CcSEcCtD
Cinacalcet—Rash—Vandetanib—thyroid cancer	0.00163	0.00484	CcSEcCtD
Cinacalcet—Dermatitis—Vandetanib—thyroid cancer	0.00163	0.00484	CcSEcCtD
Cinacalcet—Headache—Vandetanib—thyroid cancer	0.00162	0.00481	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00159	0.00472	CcSEcCtD
Cinacalcet—Dyspnoea—Sorafenib—thyroid cancer	0.00156	0.00462	CcSEcCtD
Cinacalcet—Nausea—Vandetanib—thyroid cancer	0.00154	0.00456	CcSEcCtD
Cinacalcet—Dyspepsia—Sorafenib—thyroid cancer	0.00154	0.00456	CcSEcCtD
Cinacalcet—Decreased appetite—Sorafenib—thyroid cancer	0.00152	0.0045	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00151	0.00447	CcSEcCtD
Cinacalcet—Fatigue—Sorafenib—thyroid cancer	0.00151	0.00446	CcSEcCtD
Cinacalcet—Constipation—Sorafenib—thyroid cancer	0.00149	0.00443	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00143	0.00423	CcSEcCtD
Cinacalcet—Urticaria—Sorafenib—thyroid cancer	0.00139	0.00411	CcSEcCtD
Cinacalcet—Body temperature increased—Sorafenib—thyroid cancer	0.00138	0.00409	CcSEcCtD
Cinacalcet—Abdominal pain—Sorafenib—thyroid cancer	0.00138	0.00409	CcSEcCtD
Cinacalcet—Cardiac failure—Epirubicin—thyroid cancer	0.00135	0.00399	CcSEcCtD
Cinacalcet—Pain in extremity—Epirubicin—thyroid cancer	0.00131	0.00389	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00131	0.00389	CcSEcCtD
Cinacalcet—Hypersensitivity—Sorafenib—thyroid cancer	0.00129	0.00382	CcSEcCtD
Cinacalcet—Asthenia—Sorafenib—thyroid cancer	0.00125	0.00372	CcSEcCtD
Cinacalcet—Cardiac failure—Doxorubicin—thyroid cancer	0.00125	0.00369	CcSEcCtD
Cinacalcet—Pruritus—Sorafenib—thyroid cancer	0.00124	0.00366	CcSEcCtD
Cinacalcet—Dehydration—Epirubicin—thyroid cancer	0.00122	0.00362	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00122	0.0036	CcSEcCtD
Cinacalcet—Pain in extremity—Doxorubicin—thyroid cancer	0.00122	0.0036	CcSEcCtD
Cinacalcet—Diarrhoea—Sorafenib—thyroid cancer	0.0012	0.00354	CcSEcCtD
Cinacalcet—Dizziness—Sorafenib—thyroid cancer	0.00116	0.00342	CcSEcCtD
Cinacalcet—Dehydration—Doxorubicin—thyroid cancer	0.00113	0.00335	CcSEcCtD
Cinacalcet—Vomiting—Sorafenib—thyroid cancer	0.00111	0.00329	CcSEcCtD
Cinacalcet—Rash—Sorafenib—thyroid cancer	0.0011	0.00326	CcSEcCtD
Cinacalcet—Dermatitis—Sorafenib—thyroid cancer	0.0011	0.00326	CcSEcCtD
Cinacalcet—Headache—Sorafenib—thyroid cancer	0.00109	0.00324	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00106	0.00313	CcSEcCtD
Cinacalcet—Nausea—Sorafenib—thyroid cancer	0.00104	0.00308	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000977	0.00289	CcSEcCtD
Cinacalcet—Oedema peripheral—Epirubicin—thyroid cancer	0.000895	0.00265	CcSEcCtD
Cinacalcet—Oedema peripheral—Doxorubicin—thyroid cancer	0.000829	0.00246	CcSEcCtD
Cinacalcet—Immune system disorder—Epirubicin—thyroid cancer	0.000821	0.00243	CcSEcCtD
Cinacalcet—Arrhythmia—Epirubicin—thyroid cancer	0.000812	0.00241	CcSEcCtD
Cinacalcet—Malnutrition—Epirubicin—thyroid cancer	0.000791	0.00234	CcSEcCtD
Cinacalcet—Muscle spasms—Epirubicin—thyroid cancer	0.000761	0.00225	CcSEcCtD
Cinacalcet—Immune system disorder—Doxorubicin—thyroid cancer	0.00076	0.00225	CcSEcCtD
Cinacalcet—Arrhythmia—Doxorubicin—thyroid cancer	0.000751	0.00223	CcSEcCtD
Cinacalcet—Malnutrition—Doxorubicin—thyroid cancer	0.000732	0.00217	CcSEcCtD
Cinacalcet—Anaemia—Epirubicin—thyroid cancer	0.000731	0.00217	CcSEcCtD
Cinacalcet—Muscle spasms—Doxorubicin—thyroid cancer	0.000704	0.00209	CcSEcCtD
Cinacalcet—Cough—Epirubicin—thyroid cancer	0.00069	0.00205	CcSEcCtD
Cinacalcet—Convulsion—Epirubicin—thyroid cancer	0.000686	0.00203	CcSEcCtD
Cinacalcet—Hypertension—Epirubicin—thyroid cancer	0.000683	0.00202	CcSEcCtD
Cinacalcet—Anaemia—Doxorubicin—thyroid cancer	0.000677	0.00201	CcSEcCtD
Cinacalcet—Arthralgia—Epirubicin—thyroid cancer	0.000674	0.002	CcSEcCtD
Cinacalcet—Chest pain—Epirubicin—thyroid cancer	0.000674	0.002	CcSEcCtD
Cinacalcet—Myalgia—Epirubicin—thyroid cancer	0.000674	0.002	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000669	0.00198	CcSEcCtD
Cinacalcet—Infection—Epirubicin—thyroid cancer	0.000642	0.0019	CcSEcCtD
Cinacalcet—Cough—Doxorubicin—thyroid cancer	0.000639	0.00189	CcSEcCtD
Cinacalcet—Convulsion—Doxorubicin—thyroid cancer	0.000634	0.00188	CcSEcCtD
Cinacalcet—Nervous system disorder—Epirubicin—thyroid cancer	0.000633	0.00188	CcSEcCtD
Cinacalcet—Hypertension—Doxorubicin—thyroid cancer	0.000632	0.00187	CcSEcCtD
Cinacalcet—Skin disorder—Epirubicin—thyroid cancer	0.000627	0.00186	CcSEcCtD
Cinacalcet—Chest pain—Doxorubicin—thyroid cancer	0.000623	0.00185	CcSEcCtD
Cinacalcet—Myalgia—Doxorubicin—thyroid cancer	0.000623	0.00185	CcSEcCtD
Cinacalcet—Arthralgia—Doxorubicin—thyroid cancer	0.000623	0.00185	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000619	0.00183	CcSEcCtD
Cinacalcet—Anorexia—Epirubicin—thyroid cancer	0.000616	0.00182	CcSEcCtD
Cinacalcet—Hypotension—Epirubicin—thyroid cancer	0.000603	0.00179	CcSEcCtD
Cinacalcet—Infection—Doxorubicin—thyroid cancer	0.000594	0.00176	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000588	0.00174	CcSEcCtD
Cinacalcet—Nervous system disorder—Doxorubicin—thyroid cancer	0.000586	0.00174	CcSEcCtD
Cinacalcet—Skin disorder—Doxorubicin—thyroid cancer	0.00058	0.00172	CcSEcCtD
Cinacalcet—Paraesthesia—Epirubicin—thyroid cancer	0.00058	0.00172	CcSEcCtD
Cinacalcet—Dyspnoea—Epirubicin—thyroid cancer	0.000576	0.00171	CcSEcCtD
Cinacalcet—Anorexia—Doxorubicin—thyroid cancer	0.00057	0.00169	CcSEcCtD
Cinacalcet—Dyspepsia—Epirubicin—thyroid cancer	0.000568	0.00168	CcSEcCtD
Cinacalcet—Decreased appetite—Epirubicin—thyroid cancer	0.000561	0.00166	CcSEcCtD
Cinacalcet—Hypotension—Doxorubicin—thyroid cancer	0.000558	0.00165	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000558	0.00165	CcSEcCtD
Cinacalcet—Fatigue—Epirubicin—thyroid cancer	0.000557	0.00165	CcSEcCtD
Cinacalcet—Constipation—Epirubicin—thyroid cancer	0.000552	0.00164	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000544	0.00161	CcSEcCtD
Cinacalcet—Paraesthesia—Doxorubicin—thyroid cancer	0.000537	0.00159	CcSEcCtD
Cinacalcet—Dyspnoea—Doxorubicin—thyroid cancer	0.000533	0.00158	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000528	0.00156	CcSEcCtD
Cinacalcet—Dyspepsia—Doxorubicin—thyroid cancer	0.000526	0.00156	CcSEcCtD
Cinacalcet—Decreased appetite—Doxorubicin—thyroid cancer	0.000519	0.00154	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000516	0.00153	CcSEcCtD
Cinacalcet—Fatigue—Doxorubicin—thyroid cancer	0.000515	0.00153	CcSEcCtD
Cinacalcet—Urticaria—Epirubicin—thyroid cancer	0.000513	0.00152	CcSEcCtD
Cinacalcet—Constipation—Doxorubicin—thyroid cancer	0.000511	0.00151	CcSEcCtD
Cinacalcet—Abdominal pain—Epirubicin—thyroid cancer	0.000511	0.00151	CcSEcCtD
Cinacalcet—Body temperature increased—Epirubicin—thyroid cancer	0.000511	0.00151	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000489	0.00145	CcSEcCtD
Cinacalcet—Hypersensitivity—Epirubicin—thyroid cancer	0.000476	0.00141	CcSEcCtD
Cinacalcet—Urticaria—Doxorubicin—thyroid cancer	0.000475	0.00141	CcSEcCtD
Cinacalcet—Abdominal pain—Doxorubicin—thyroid cancer	0.000472	0.0014	CcSEcCtD
Cinacalcet—Body temperature increased—Doxorubicin—thyroid cancer	0.000472	0.0014	CcSEcCtD
Cinacalcet—Asthenia—Epirubicin—thyroid cancer	0.000463	0.00137	CcSEcCtD
Cinacalcet—Pruritus—Epirubicin—thyroid cancer	0.000457	0.00135	CcSEcCtD
Cinacalcet—Diarrhoea—Epirubicin—thyroid cancer	0.000442	0.00131	CcSEcCtD
Cinacalcet—Hypersensitivity—Doxorubicin—thyroid cancer	0.00044	0.0013	CcSEcCtD
Cinacalcet—Asthenia—Doxorubicin—thyroid cancer	0.000429	0.00127	CcSEcCtD
Cinacalcet—Dizziness—Epirubicin—thyroid cancer	0.000427	0.00127	CcSEcCtD
Cinacalcet—Pruritus—Doxorubicin—thyroid cancer	0.000423	0.00125	CcSEcCtD
Cinacalcet—Vomiting—Epirubicin—thyroid cancer	0.000411	0.00122	CcSEcCtD
Cinacalcet—Diarrhoea—Doxorubicin—thyroid cancer	0.000409	0.00121	CcSEcCtD
Cinacalcet—Rash—Epirubicin—thyroid cancer	0.000407	0.00121	CcSEcCtD
Cinacalcet—Dermatitis—Epirubicin—thyroid cancer	0.000407	0.00121	CcSEcCtD
Cinacalcet—Headache—Epirubicin—thyroid cancer	0.000405	0.0012	CcSEcCtD
Cinacalcet—Dizziness—Doxorubicin—thyroid cancer	0.000395	0.00117	CcSEcCtD
Cinacalcet—Nausea—Epirubicin—thyroid cancer	0.000384	0.00114	CcSEcCtD
Cinacalcet—Vomiting—Doxorubicin—thyroid cancer	0.00038	0.00113	CcSEcCtD
Cinacalcet—Rash—Doxorubicin—thyroid cancer	0.000377	0.00112	CcSEcCtD
Cinacalcet—Dermatitis—Doxorubicin—thyroid cancer	0.000376	0.00112	CcSEcCtD
Cinacalcet—Headache—Doxorubicin—thyroid cancer	0.000374	0.00111	CcSEcCtD
Cinacalcet—Nausea—Doxorubicin—thyroid cancer	0.000355	0.00105	CcSEcCtD
